MedVellum
MedVellum
Back to Library
Haematology
Emergency Medicine
Vascular Medicine

Deep Vein Thrombosis

High EvidenceUpdated: 2026-01-01

On This Page

Red Flags

  • Proximal DVT (higher PE risk)
  • Phlegmasia (limb-threatening)
  • Concurrent PE symptoms
Overview

Deep Vein Thrombosis

1. Clinical Overview

Summary

Deep vein thrombosis (DVT) is clot formation in the deep veins, most commonly in the legs. It can be asymptomatic or present with leg pain, swelling, and warmth. Proximal DVT (above knee) carries higher risk of pulmonary embolism. Diagnosis uses Wells score to determine pre-test probability, followed by D-dimer or ultrasound. Treatment is anticoagulation with DOACs preferred.

Key Facts

  • Definition: Thrombosis in deep venous system
  • Incidence: 1-2 per 1,000 per year
  • Pathognomonic: Unilateral leg swelling + risk factors
  • Gold Standard Investigation: Compression ultrasound
  • First-line Treatment: DOACs (rivaroxaban, apixaban)
  • Prognosis: Good with treatment; PTS in 20-50%

Clinical Pearls

Wells Pearl: DVT unlikely (0-1) + negative D-dimer = DVT excluded.

Proximal Pearl: Proximal DVT needs treatment; calf DVT controversial.

DOAC Pearl: Rivaroxaban/apixaban don't need bridging with LMWH.


2. Wells Score for DVT
CriteriaPoints
Active cancer1
Paralysis/recent immobilisation1
Bedridden greater than 3d or surgery within 12 weeks1
Tenderness along deep veins1
Entire leg swollen1
Calf swelling greater than 3cm vs other side1
Pitting oedema1
Collateral superficial veins1
Previous DVT1
Alternative diagnosis more likely-2

3. Management

Algorithm

DVT Algorithm

Anticoagulation

DrugRegimen
Rivaroxaban15mg BD x21d then 20mg OD
Apixaban10mg BD x7d then 5mg BD
LMWH/WarfarinAlternative

Duration

TypeDuration
Provoked3 months
Unprovoked6+ months or indefinite
CancerLMWH or DOAC long-term

4. References
  1. NICE guideline NG158. Venous thromboembolic diseases. 2020.

  2. Kearon C et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline. Chest. 2016;149(2):315-352. PMID: 26867832


5. Examination Focus

Viva Points

"DVT: Wells score for probability. Unlikely + negative D-dimer = excluded. USS if likely. DOACs first-line. Duration: provoked 3m, unprovoked longer."


Last Reviewed: 2026-01-01 | MedVellum Editorial Team

Last updated: 2026-01-01

At a Glance

EvidenceHigh
Last Updated2026-01-01

Red Flags

  • Proximal DVT (higher PE risk)
  • Phlegmasia (limb-threatening)
  • Concurrent PE symptoms

Clinical Pearls

  • **Wells Pearl**: DVT unlikely (0-1) + negative D-dimer = DVT excluded.
  • **Proximal Pearl**: Proximal DVT needs treatment; calf DVT controversial.
  • **DOAC Pearl**: Rivaroxaban/apixaban don't need bridging with LMWH.
  • "DVT: Wells score for probability. Unlikely + negative D-dimer = excluded. USS if likely. DOACs first-line. Duration: provoked 3m, unprovoked longer."

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines